Researchers have successfully used artificial intelligence (AI) to predict which patients need treatment to stabilize their corneas and preserve their eyesight, in a study presented at the 43rd Congress of the European Society ...
Sep 13, 2025
0
27
Combining artificial intelligence and genetics has allowed researchers to study the part of the eye that gives us sharp central vision in amazing detail for the first time.
Sep 20, 2025
0
27
Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and stroke among adults aged 50 years or older, according to a study published ...
Aug 19, 2025
0
27
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (IOP) daily. The current tools for IOP measurement are not portable, convenient, easily accessible, or ...
Jan 27, 2026
0
28
Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual function in stroke patients who have suffered vision loss following a stroke. The approach could offer ...
Nov 17, 2025
0
39
A team of researchers at the University of Oxford have unveiled a pioneering "microstent" which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation.
Aug 19, 2025
0
26
Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...
May 4, 2026
0
25
Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.
Oct 2, 2025
0
25
John A. Moran Eye Center researcher Adam Dubis, Ph.D., is part of a big leap forward for the use of artificial intelligence in eye care.
Aug 7, 2025
0
25
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a reduced risk for certain complications ...
Aug 12, 2025
0
25
